| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Impact of the extent of surgery and postoperative chemoradiotherapy on recurrence patterns in gastric cancer.
|
J Clin Oncol
|
2010
|
2.29
|
|
2
|
Selection of patients for radiotherapy with protons aiming at reduction of side effects: the model-based approach.
|
Radiother Oncol
|
2013
|
2.11
|
|
3
|
Ceramide: second messenger or modulator of membrane structure and dynamics?
|
Biochem J
|
2003
|
2.06
|
|
4
|
The New American Joint Committee on Cancer/International Union Against Cancer staging system for adenocarcinoma of the stomach: increased complexity without clear improvement in predictive accuracy.
|
Ann Surg Oncol
|
2012
|
1.87
|
|
5
|
Neo-adjuvant chemotherapy followed by surgery and chemotherapy or by surgery and chemoradiotherapy for patients with resectable gastric cancer (CRITICS).
|
BMC Cancer
|
2011
|
1.76
|
|
6
|
Optimal locoregional treatment in gastric cancer.
|
J Clin Oncol
|
2005
|
1.54
|
|
7
|
Tumor radiosensitizers--current status of development of various approaches: report of an International Atomic Energy Agency meeting.
|
Int J Radiat Oncol Biol Phys
|
2006
|
1.48
|
|
8
|
Anti-cancer alkyl-lysophospholipids inhibit the phosphatidylinositol 3-kinase-Akt/PKB survival pathway.
|
Anticancer Drugs
|
2003
|
1.35
|
|
9
|
Apoptosis-modulating agents in combination with radiotherapy-current status and outlook.
|
Int J Radiat Oncol Biol Phys
|
2004
|
1.27
|
|
10
|
Anticancer alkylphospholipids: mechanisms of action, cellular sensitivity and resistance, and clinical prospects.
|
Curr Pharm Des
|
2008
|
1.21
|
|
11
|
Prospective study on late renal toxicity following postoperative chemoradiotherapy in gastric cancer.
|
Int J Radiat Oncol Biol Phys
|
2006
|
1.20
|
|
12
|
Increased incidence and survival for oesophageal cancer but not for gastric cardia cancer in the Netherlands.
|
Eur J Cancer
|
2012
|
1.18
|
|
13
|
Resistance to alkyl-lysophospholipid-induced apoptosis due to downregulated sphingomyelin synthase 1 expression with consequent sphingomyelin- and cholesterol-deficiency in lipid rafts.
|
Biochem J
|
2007
|
1.18
|
|
14
|
In vivo imaging of apoptosis by 99mTc-Annexin V scintigraphy: visual analysis in relation to treatment response.
|
Radiother Oncol
|
2004
|
1.17
|
|
15
|
A new class of anticancer alkylphospholipids uses lipid rafts as membrane gateways to induce apoptosis in lymphoma cells.
|
Mol Cancer Ther
|
2007
|
1.17
|
|
16
|
Anticancer mechanisms and clinical application of alkylphospholipids.
|
Biochim Biophys Acta
|
2012
|
1.11
|
|
17
|
Prognostic significance of 99mTc Hynic-rh-annexin V scintigraphy during platinum-based chemotherapy in advanced lung cancer.
|
J Clin Oncol
|
2007
|
1.10
|
|
18
|
Alkyl-lysophospholipid accumulates in lipid rafts and induces apoptosis via raft-dependent endocytosis and inhibition of phosphatidylcholine synthesis.
|
J Biol Chem
|
2002
|
1.10
|
|
19
|
In vivo imaging of radiation-induced apoptosis in follicular lymphoma patients.
|
Int J Radiat Oncol Biol Phys
|
2004
|
1.08
|
|
20
|
AT-101, a small molecule inhibitor of anti-apoptotic Bcl-2 family members, activates the SAPK/JNK pathway and enhances radiation-induced apoptosis.
|
Radiat Oncol
|
2009
|
1.06
|
|
21
|
In vivo p53 response and immune reaction underlie highly effective low-dose radiotherapy in follicular lymphoma.
|
Blood
|
2007
|
1.04
|
|
22
|
Rationale and clinical application of alkylphospholipid analogues in combination with radiotherapy.
|
Cancer Treat Rev
|
2007
|
1.03
|
|
23
|
Treatment of resectable gastric cancer.
|
Therap Adv Gastroenterol
|
2012
|
0.99
|
|
24
|
99mTc Hynic-rh-Annexin V scintigraphy for in vivo imaging of apoptosis in patients with head and neck cancer treated with chemoradiotherapy.
|
Eur J Nucl Med Mol Imaging
|
2007
|
0.98
|
|
25
|
Adaptive and innovative Radiation Treatment FOR improving Cancer treatment outcomE (ARTFORCE); a randomized controlled phase II trial for individualized treatment of head and neck cancer.
|
BMC Cancer
|
2013
|
0.96
|
|
26
|
Conditional probability of survival nomogram for 1-, 2-, and 3-year survivors after an R0 resection for gastric cancer.
|
Ann Surg Oncol
|
2012
|
0.95
|
|
27
|
Interobserver variation of clinical target volume delineation in gastric cancer.
|
Int J Radiat Oncol Biol Phys
|
2009
|
0.94
|
|
28
|
Tumor and normal tissue pharmacokinetics of perifosine, an oral anti-cancer alkylphospholipid.
|
Invest New Drugs
|
2005
|
0.94
|
|
29
|
Targeted radiosensitization by the Chk1 inhibitor SAR-020106.
|
Int J Radiat Oncol Biol Phys
|
2012
|
0.93
|
|
30
|
99mTc-HYNIC-rh-annexin-V scintigraphy: visual and quantitative evaluation of early treatment-induced apoptosis to predict treatment outcome.
|
Nucl Med Commun
|
2008
|
0.92
|
|
31
|
Radiosensitization of squamous cell carcinoma by the alkylphospholipid perifosine in cell culture and xenografts.
|
Clin Cancer Res
|
2006
|
0.91
|
|
32
|
Enriching lipid nanovesicles with short-chain glucosylceramide improves doxorubicin delivery and efficacy in solid tumors.
|
FASEB J
|
2010
|
0.91
|
|
33
|
Antiapoptotic potency of Bcl-2 proteins primarily relies on their stability, not binding selectivity.
|
Blood
|
2014
|
0.90
|
|
34
|
Phase I and pharmacokinetic study of combined treatment with perifosine and radiation in patients with advanced solid tumours.
|
Radiother Oncol
|
2006
|
0.90
|
|
35
|
Centralization of esophagectomy: how far should we go?
|
Ann Surg Oncol
|
2014
|
0.89
|
|
36
|
Prediction of treatment outcome by cisplatin-DNA adduct formation in patients with stage III/IV head and neck squamous cell carcinoma, treated by concurrent cisplatin-radiation (RADPLAT).
|
Int J Cancer
|
2006
|
0.88
|
|
37
|
A phase I-II study of postoperative capecitabine-based chemoradiotherapy in gastric cancer.
|
Int J Radiat Oncol Biol Phys
|
2007
|
0.87
|
|
38
|
The curative outcome of radioimmunotherapy in a mouse breast cancer model relies on mTOR signaling.
|
Radiat Res
|
2014
|
0.85
|
|
39
|
Lipid rafts and metabolic energy differentially determine uptake of anti-cancer alkylphospholipids in lymphoma versus carcinoma cells.
|
Biochem Pharmacol
|
2007
|
0.85
|
|
40
|
TRAIL enhances efficacy of radiotherapy in a p53 mutant, Bcl-2 overexpressing lymphoid malignancy.
|
Radiother Oncol
|
2006
|
0.85
|
|
41
|
Questioning the value of (99m)Tc-HYNIC-annexin V based response monitoring after docetaxel treatment in a mouse model for hereditary breast cancer.
|
Appl Radiat Isot
|
2010
|
0.84
|
|
42
|
Effect of hospital volume on postoperative mortality and survival after oesophageal and gastric cancer surgery in the Netherlands between 1989 and 2009.
|
Eur J Cancer
|
2012
|
0.84
|
|
43
|
Coformulated N-octanoyl-glucosylceramide improves cellular delivery and cytotoxicity of liposomal doxorubicin.
|
J Pharmacol Exp Ther
|
2005
|
0.82
|
|
44
|
Quality of care indicators for the surgical treatment of gastric cancer: a systematic review.
|
Ann Surg Oncol
|
2012
|
0.82
|
|
45
|
Alkylphospholipids inhibit capillary-like endothelial tube formation in vitro: antiangiogenic properties of a new class of antitumor agents.
|
Anticancer Drugs
|
2008
|
0.81
|
|
46
|
Different modes of internalization of apoptotic alkyl-lysophospholipid and cell-rescuing lysophosphatidylcholine.
|
Biochem J
|
2003
|
0.81
|
|
47
|
Combining radiotherapy with APO010 in cancer treatment.
|
Clin Cancer Res
|
2009
|
0.81
|
|
48
|
Imaging radiotherapy-induced apoptosis.
|
Radiat Res
|
2012
|
0.79
|
|
49
|
Mapping of treatment-induced apoptosis in normal structures: 99mTc-Hynic-rh-annexin V SPECT and CT image fusion.
|
Eur J Nucl Med Mol Imaging
|
2006
|
0.79
|
|
50
|
The prognostic significance of an R1 resection in gastric cancer patients treated with adjuvant chemoradiotherapy.
|
Ann Surg Oncol
|
2013
|
0.79
|
|
51
|
Extended lymph node dissection for gastric cancer from a European perspective.
|
Gastric Cancer
|
2011
|
0.78
|
|
52
|
Short-chain glycoceramides promote intracellular mitoxantrone delivery from novel nanoliposomes into breast cancer cells.
|
Pharm Res
|
2014
|
0.77
|
|
53
|
Fas/CD95 down-regulation in lymphoma cells through acquired alkyllysophospholipid resistance: partial role of associated sphingomyelin deficiency.
|
Biochem J
|
2009
|
0.77
|
|
54
|
Defined lipid analogues induce transient channels to facilitate drug-membrane traversal and circumvent cancer therapy resistance.
|
Sci Rep
|
2013
|
0.77
|
|
55
|
Phosphoinositide phosphatase SHIP-1 regulates apoptosis induced by edelfosine, Fas ligation and DNA damage in mouse lymphoma cells.
|
Biochem J
|
2011
|
0.77
|
|
56
|
Submicromolar doses of alkyl-lysophospholipids induce rapid internalization, but not activation, of epidermal growth factor receptor and concomitant MAPK/ERK activation in A431 cells.
|
Int J Cancer
|
2002
|
0.76
|
|
57
|
Thallium-201-chloride scintigraphy in staging and monitoring radiotherapy response in follicular lymphoma patients.
|
Radiother Oncol
|
2003
|
0.76
|
|
58
|
Combining anti-tumor alkyl-phospholipid analogs and radiotherapy: rationale and clinical outlook.
|
Anticancer Agents Med Chem
|
2014
|
0.76
|
|
59
|
Does adjuvant chemoradiotherapy improve the prognosis of gastric cancer after an r1 resection? Results from a dutch cohort study.
|
Ann Surg Oncol
|
2014
|
0.75
|
|
60
|
Improving intracellular doxorubicin delivery through nanoliposomes equipped with selective tumor cell membrane permeabilizing short-chain sphingolipids.
|
Pharm Res
|
2013
|
0.75
|
|
61
|
Surgicopathological Quality Control and Protocol Adherence to Lymphadenectomy in the CRITICS Gastric Cancer Trial.
|
Ann Surg
|
2017
|
0.75
|
|
62
|
Predicting early chemotherapy response with technetium-99m methoxyisobutylisonitrile SPECT/CT in advanced non-small cell lung cancer.
|
Mol Imaging Biol
|
2009
|
0.75
|
|
63
|
Sensitization of drug resistant sarcoma tumors by membrane modulation via short chain sphingolipid-containing nanoparticles.
|
Nanoscale
|
2020
|
0.75
|
|
64
|
Can adjuvant chemoradiotherapy replace extended lymph node dissection in gastric cancer?
|
Recent Results Cancer Res
|
2012
|
0.75
|
|
65
|
Randomized trials and quality assurance in gastric cancer surgery.
|
J Surg Oncol
|
2012
|
0.75
|
|
66
|
Obituary: Adrian C. Begg.
|
Radiother Oncol
|
2014
|
0.75
|